Orthopediatrics Capital Expenditures (CapEx) Growth & History (KIDS)
Orthopediatrics's capital expenditures (capex) was $11.1M for fiscal 2025.
View full Orthopediatrics company overviewOrthopediatrics annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $11.1M | −$3.2M | −22.11% |
| 2024 | 2024-12-31 | $14.3M | −$2.6M | −15.49% |
| 2023 | 2023-12-31 | $16.9M | $6.8M | +68.26% |
| 2022 | 2022-12-31 | $10.0M | $1.9M | +23.79% |
| 2021 | 2021-12-31 | $8.1M | −$2.4M | −22.86% |
| 2020 | 2020-12-31 | $10.5M | −$1.3M | −11.10% |
| 2019 | 2019-12-31 | $11.8M | $6.6M | +124.94% |
| 2018 | 2018-12-31 | $5.3M | $46,000 | +0.88% |
| 2017 | 2017-12-31 | $5.2M | $859,000 | +19.76% |
| 2016 | 2016-12-31 | $4.3M | $2.1M | +96.65% |
| 2015 | 2015-12-31 | $2.2M | — | — |
Orthopediatrics quarterly capital expenditures (capex)
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $4.0M | $600,000 | +17.42% |
| Q1 2026 | 2026-03-31 | $1.8M | −$2.5M | −58.36% |
| Q4 2025 | 2025-12-31 | $599,000 | $337,000 | +128.63% |
| Q3 2025 | 2025-09-30 | $2.8M | $1.5M | +105.58% |
| Q2 2025 | 2025-06-30 | $3.4M | −$3.2M | −48.46% |
| Q1 2025 | 2025-03-31 | $4.2M | −$2.2M | −34.57% |
| Q4 2024 | 2024-12-31 | $262,000 | −$3.6M | −93.17% |
| Q3 2024 | 2024-09-30 | $1.4M | −$1.1M | −44.29% |
| Q2 2024 | 2024-06-30 | $6.7M | $1.1M | +18.87% |
| Q1 2024 | 2024-03-31 | $6.5M | $1.5M | +30.77% |
| Q4 2023 | 2023-12-31 | $3.8M | $3.3M | +633.46% |
| Q3 2023 | 2023-09-30 | $2.5M | $1.4M | +127.64% |
| Q2 2023 | 2023-06-30 | $5.6M | $355,000 | +6.74% |
| Q1 2023 | 2023-03-31 | $4.9M | $743,000 | +17.70% |
| Q4 2022 | 2022-12-31 | $523,000 | −$1.1M | −68.01% |
| Q3 2022 | 2022-09-30 | $1.1M | −$905,000 | −45.39% |
| Q2 2022 | 2022-06-30 | $5.3M | $3.5M | +205.39% |
| Q1 2022 | 2022-03-31 | $4.2M | $1.4M | +52.67% |
| Q4 2021 | 2021-12-31 | $1.6M | −$2.4M | −59.69% |
| Q3 2021 | 2021-09-30 | $2.0M | $706,000 | +54.81% |
| Q2 2021 | 2021-06-30 | $1.7M | $518,000 | +42.92% |
| Q1 2021 | 2021-03-31 | $2.7M | −$1.2M | −30.46% |
| Q4 2020 | 2020-12-31 | $4.1M | $2.8M | +216.88% |
| Q3 2020 | 2020-09-30 | $1.3M | −$734,000 | −36.30% |
| Q2 2020 | 2020-06-30 | $1.2M | −$2.3M | −66.01% |
| Q1 2020 | 2020-03-31 | $4.0M | −$1.0M | −20.35% |
| Q4 2019 | 2019-12-31 | $1.3M | $1.2M | +2106.90% |
| Q3 2019 | 2019-09-30 | $2.0M | $878,000 | +76.75% |
| Q2 2019 | 2019-06-30 | $3.6M | $2.2M | +154.37% |
| Q1 2019 | 2019-03-31 | $5.0M | $2.2M | +79.11% |
| Q4 2018 | 2018-12-31 | $58,000 | −$1.2M | −95.39% |
| Q3 2018 | 2018-09-30 | $1.1M | $39,000 | +3.53% |
| Q2 2018 | 2018-06-30 | $1.4M | −$116,000 | −7.67% |
| Q1 2018 | 2018-03-31 | $2.8M | $1.4M | +108.03% |
| Q4 2017 | 2017-12-31 | $1.3M | — | — |
| Q3 2017 | 2017-09-30 | $1.1M | — | — |
| Q2 2017 | 2017-06-30 | $1.5M | — | — |
| Q1 2017 | 2017-03-31 | $1.3M | — | — |
Orthopediatrics capital expenditures (capex) trends
Over the last five fiscal years, Orthopediatrics's capital expenditures (capex) increased from $10.5M to $11.1M, a change of $606,000. The latest reported quarter, Q2 2026, shows $4.0M.
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Orthopediatrics source filings ↗